RM

Ranjana Mandalgi

Director Director DIN 00225090
DIN 00225090 First appointment Apr 2004 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2004
Shareholding value Locked Premium profile

About Ranjana Mandalgi

Ranjana Mandalgi has 22 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 00225090
Primary Designation Director
First Appointment 16 Apr 2004
Oldest Company Age 22 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Zoricon Pharmaceuticals Private Limited U24233MP2004PTC016550
Director 16 Apr 2004 2004 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zoricon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ranjana Mandalgi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjana Mandalgi

Ranjana Mandalgi has 22 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ranjana Mandalgi is associated with 0 companies as Director.

Ranjana Mandalgi has expertise in General Business.

Ranjana Mandalgi has 22 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available